A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants with Obesity or Overweight, without Type 2 Diabetes (ENLIGHTEN-1)

16961J3R-MC-YDAG-MGSHOpenA Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants with Obesity or Overweight, without Type 2 Diabetes (ENLIGHTEN-1) J3R-MC-YDAGNCT07321886IndustrialAdultTreatmentOtherGhazi, AdlineMedStar Health and GUMC; Medstar Good Samaritan HospitalMHRI Community Research2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>